Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties
- PMID: 28464237
- DOI: 10.1002/bit.26326
Ultrafiltration behavior of monoclonal antibodies and Fc-fusion proteins: Effects of physical properties
Abstract
Ultrafiltration (UF) is used for the final concentration and formulation of essentially all antibody-based therapeutics including both monoclonal antibodies (mAbs) and Fc-fusion proteins. The objective of this study was to quantitatively compare the filtrate flux behavior for two highly purified mAbs and an Fc-fusion protein under identical flow and buffer conditions. Filtrate flux data were obtained using a Pellicon 3 tangential flow filtration cassette over a wide range of transmembrane pressures and bulk protein concentrations. Independent experimental measurements were performed to evaluate the protein osmotic pressure and solution viscosity. The maximum achievable protein concentration was directly correlated with the solution viscosity, which controls the pressure drop and extent of back-filtration in the cassette. The filtrate flux data were analyzed using a recently developed model that accounts for the effects of intermolecular interactions and transmembrane pressure gradients on the extent of concentration polarization. These results provide important insights into the factors controlling the filtrate flux during the UF of concentrated protein solutions and an effective framework for the design/analysis of UF processes for the formulation of antibody-based therapeutics. Biotechnol. Bioeng. 2017;114: 2057-2065. © 2017 Wiley Periodicals, Inc.
Keywords: Fc-fusion protein; concentration polarization; intermolecular interactions; monoclonal antibody; physical properties; ultrafiltration; viscosity.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions.Biotechnol Prog. 2016 May;32(3):692-701. doi: 10.1002/btpr.2252. Epub 2016 May 17. Biotechnol Prog. 2016. PMID: 26918655
-
Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.Biotechnol Bioeng. 2017 Sep;114(9):2043-2056. doi: 10.1002/bit.26329. Epub 2017 May 26. Biotechnol Bioeng. 2017. PMID: 28464235 Free PMC article.
-
Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review.Biotechnol Bioeng. 2020 Nov;117(11):3591-3606. doi: 10.1002/bit.27510. Epub 2020 Aug 3. Biotechnol Bioeng. 2020. PMID: 32687221 Review.
-
High concentration biotherapeutic formulation and ultrafiltration: Part 1 pressure limits.Biotechnol Prog. 2017 Jan;33(1):113-124. doi: 10.1002/btpr.2334. Epub 2016 Oct 15. Biotechnol Prog. 2017. PMID: 27452237
-
Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins.Curr Opin Biotechnol. 2018 Oct;53:59-64. doi: 10.1016/j.copbio.2017.12.016. Epub 2017 Dec 23. Curr Opin Biotechnol. 2018. PMID: 29278833 Review.
Cited by
-
Structure, heterogeneity and developability assessment of therapeutic antibodies.MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17. MAbs. 2019. PMID: 30543482 Free PMC article. Review.
-
White paper on high-throughput process development for integrated continuous biomanufacturing.Biotechnol Bioeng. 2021 Sep;118(9):3275-3286. doi: 10.1002/bit.27757. Epub 2021 Apr 2. Biotechnol Bioeng. 2021. PMID: 33749840 Free PMC article. Review.
-
Stability of Protein Pharmaceuticals: Recent Advances.Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27. Pharm Res. 2024. PMID: 38937372 Review.
-
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties.MAbs. 2023 Jan-Dec;15(1):2164459. doi: 10.1080/19420862.2022.2164459. MAbs. 2023. PMID: 36629855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources